1. Home
  2. VYGR vs KLTR Comparison

VYGR vs KLTR Comparison

Compare VYGR & KLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • KLTR
  • Stock Information
  • Founded
  • VYGR 2013
  • KLTR 2006
  • Country
  • VYGR United States
  • KLTR United States
  • Employees
  • VYGR N/A
  • KLTR N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • KLTR EDP Services
  • Sector
  • VYGR Health Care
  • KLTR Technology
  • Exchange
  • VYGR Nasdaq
  • KLTR Nasdaq
  • Market Cap
  • VYGR 342.5M
  • KLTR 389.2M
  • IPO Year
  • VYGR 2015
  • KLTR 2021
  • Fundamental
  • Price
  • VYGR $5.22
  • KLTR $2.30
  • Analyst Decision
  • VYGR Strong Buy
  • KLTR Buy
  • Analyst Count
  • VYGR 9
  • KLTR 2
  • Target Price
  • VYGR $15.53
  • KLTR $2.25
  • AVG Volume (30 Days)
  • VYGR 361.6K
  • KLTR 719.6K
  • Earning Date
  • VYGR 02-26-2025
  • KLTR 02-20-2025
  • Dividend Yield
  • VYGR N/A
  • KLTR N/A
  • EPS Growth
  • VYGR N/A
  • KLTR N/A
  • EPS
  • VYGR 0.47
  • KLTR N/A
  • Revenue
  • VYGR $163,784,000.00
  • KLTR $177,586,000.00
  • Revenue This Year
  • VYGR N/A
  • KLTR $3.34
  • Revenue Next Year
  • VYGR N/A
  • KLTR $1.88
  • P/E Ratio
  • VYGR $11.19
  • KLTR N/A
  • Revenue Growth
  • VYGR 3.40
  • KLTR 1.62
  • 52 Week Low
  • VYGR $4.99
  • KLTR $0.76
  • 52 Week High
  • VYGR $10.66
  • KLTR $2.82
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 38.79
  • KLTR 52.15
  • Support Level
  • VYGR $4.99
  • KLTR $2.23
  • Resistance Level
  • VYGR $5.45
  • KLTR $2.40
  • Average True Range (ATR)
  • VYGR 0.26
  • KLTR 0.19
  • MACD
  • VYGR -0.05
  • KLTR -0.02
  • Stochastic Oscillator
  • VYGR 17.97
  • KLTR 41.57

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

Share on Social Networks: